Bio-Rad, Myriad RBM Partner on Biomarker Kits | GenomeWeb

NEW YORK (GenomeWeb News) – Bio-Rad Laboratories and Myriad RBM said after the close of the market on Tuesday they are partnering to develop and distribute immunoassays kits.

Myriad RBM, a subsidiary of Myriad Genetics formed when it acquired Rules-Based Medicine last year, is granting Bio-Rad exclusive distribution rights, for research purposes, to it catalog of quantitative multiplexed immunoassays to run on Bio-Rad's Bio-Plex 200, Bio-Plex 3D, and Bio-Plex MagPix instruments.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.

Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.